Vidwan-ID : 144182



  • Dr Sathish Kumar Konidala

  • Assistant Professor (Grade-I)
  • Vignans Foundation for Science, Technology and Research
Publications 2011 - 2019

Publications

  • 29
    Journal Articles
  • 1
    Review
  • 3
    Projects
  • 1

Citations / H-Index

14 Citations
1 h-index
9 Citations

Google Scholar

Co-author Network


Expertise

Pharmacology and Pharmacy

Pharmaceutical Analysis and Pharmaceutical Chemistry

Personal Information

Dr Sathish Kumar Konidala

Male
Department of Pharmaceutical Sciences Vignan's Foundation for Science Technology and Research (Deemed to be University)
Guntur, Andhra Pradesh, India - 522213


Experience

  • Assistant Professor (Grade-I)

    Department of Pharmaceutical Sciences

    Vignans Foundation for Science, Technology and Research

  • Research Fellow

    ANU College of Pharmaceutical Sciences

    Acharya Nagarjuna University

  • Assistant Professor

    Pharmaceutical Analysis and Quality Assurance

    ADITYA INSTITUTE OF PHARMACEUTICAL SCIENCES AND RESEARCH

  • Assistant Professor

    Pharmaceutical Analysis

    Siddhartha Institute of Pharmaceutical Sciences, Jonnalagadda


Qualification

  • Ph.D.

    Acharya Nagarjuna University

  • M.Pharm

    Acharya Nagarjuna University

  • B. Pharm

    Bapatla College of Pharmacy


Honours and Awards

2021

Research Excellence certificate

Vignan's Foundation for Science Technology and Research (Deemed to be University)

2020

Young Researcher Award

Institute of Scholars (InSc)

2021

Research Excellence certificate

Vignan's Foundation for Science Technology and Research (Deemed to be University)

2020

Young Researcher Award

Institute of Scholars (InSc)

Read Less

Membership In Professional Bodies

2021

APTI

AP/LM-717

2021

APTI

AP/LM-717

Read Less

Membership In Committees

2021

Board of Examinations, VFSTR

Member

2021

Board of Examinations, VFSTR

Member

Read Less

Research Projects

Novel fluoro substituted heterocyclic hybrids as promising anti-diabetic compounds: Design, Synthesis, Characterization, and Biological Screening

Funding Agency : DST-SERB-TARE

Simultaneous Determination and impurity profiling of Anticancer Drugs using RP-HPLC in Active Pharmaceutical Ingredients and in vitro pharmacokinetic evaluation of Tablet formulation

Funding Agency : Vignan's Foundation for Science Technology and Research (Deemed to University)

Novel fluoro substituted heterocyclic hybrids as promising anti-diabetic compounds: Design, Synthesis, Characterization, and Biological Screening

Funding Agency : DST-SERB-TARE

Novel fluoro substituted heterocyclic hybrids as promising anti-diabetic compounds: Design, Synthesis, Characterization, and Biological Screening

Funding Agency : DST-SERB-TARE

Simultaneous Determination and impurity profiling of Anticancer Drugs using RP-HPLC in Active Pharmaceutical Ingredients and in vitro pharmacokinetic evaluation of Tablet formulation

Funding Agency : Vignan's Foundation for Science Technology and Research (Deemed to University)

Novel fluoro substituted heterocyclic hybrids as promising anti-diabetic compounds: Design, Synthesis, Characterization, and Biological Screening

Funding Agency : DST-SERB-TARE

Read Less

Patents





Read Less